Most people haven’t heard of the condition, but Friedreich’s ataxia is getting more attention because of a new treatment and ...

Larimar Therapeutics' CTI-1601 offers hope for Friedreich's ataxia patients, with promising trial results. Check out why LRMR ...

Panelists discuss how the differential diagnosis for Friedreich's Ataxia involves distinguishing it from other ataxias, the ...

There is currently no cure for Friedreich’s ataxia. Treatment focuses on managing your symptoms and improving your quality of life to help you maintain your daily function and activities as long ...

In order to improve the quality of life of patients with the Ataxia disease, the biotechnological and pharmaceutical industry ...

A Friedreich ataxia specialist discusses how the typical clinical presentation of Friedreich's Ataxia includes early onset with symptoms such as ataxia and sensory loss, while also examining the ...

The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...

Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell ...

Genetic analysis beyond the causative variants, and independent of the core clinical symptoms (pyramidal signs versus ataxia), might offer a more pertinent way to approach phenotypic variability.

With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.

Shares of Biohaven climbed 13% premarket on Monday after the biotech company said its treatment for a rare neurological ...

Bill Nye, who has helped make science a part of pop culture for a generation of adults and children, is now using his ...